New COVID booster tested on teens
NCT ID NCT06234956
Summary
This study tested a COVID-19 booster vaccine called BIMERVAX in teenagers aged 12 to 18. The goal was to see how safe it was and how well it boosted the immune system against the virus, especially newer variants. All participants had received two Pfizer shots at least six months earlier and were followed for one year after getting the booster.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SARS-COV-2 INFECTION are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
CAP Centelles
Centelles, Barcelona, 08540, Spain
-
CAP Peralada
Peralada, Girona, 17491, Spain
-
Hospital HM Montepríncipe
Boadilla del Monte, Madrid, 28660, Spain
-
Hospital HM Puerta del Sur
Móstoles, Madrid, 28938, Spain
-
Hospital Josep Trueta
Girona, Girona, 17007, Spain
-
Hospital La Paz
Madrid, Madrid, 28046, Spain
-
Hospital Vall Hebron
Barcelona, Barcelona, 08035, Spain
Conditions
Explore the condition pages connected to this study.